Efficacy and Tolerability of an Aliskiren-based Treatment Algorithm in Patients With Mild to Moderate Hypertension
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
This study will assess the efficacy of an aliskiren based treatment regimen in reaching blood
pressure (BP) target in patients with mild to moderate hypertension. (defined as mean sitting
Systolic Blood Pressure [msSBP] ≥ 140 mmHg and < 180 mmHg and/or mean sitting Diastolic Blood
Pressure [msDBP] ≥ 90 and <110 mmHg).